Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

dbSNP Short Genetic Variations

Welcome to the Reference SNP (rs) Report

All alleles are reported in the Forward orientation. Click on the Variant Details tab for details on Genomic Placement, Gene, and Amino Acid changes. HGVS names are in the HGVS tab.

Reference SNP (rs) Report

This page reports data for a single dbSNP Reference SNP variation (RefSNP or rs) from the new redesigned dbSNP build.
Top of the page reports a concise summary for the rs, with more specific details included in the corresponding tabs below.
All alleles are reported in the Forward orientation. Use the Genomic View to inspect the nucleotides flanking the variant, and its neighbors.
For more information see Help documentation.

rs5985

Current Build 156

Released September 21, 2022

Organism
Homo sapiens
Position
chr6:6318562 (GRCh38.p14) Help

The anchor position for this RefSNP. Includes all nucleotides potentially affected by this change, thus it can differ from HGVS, which is right-shifted. See here for details.

Alleles
C>A / C>T
Variation Type
SNV Single Nucleotide Variation
Frequency
A=0.230532 (80651/349848, ALFA)
A=0.216691 (57356/264690, TOPMED)
A=0.220019 (30778/139888, GnomAD) (+ 21 more)
A=0.17830 (14032/78698, PAGE_STUDY)
T=0.00032 (9/28258, 14KJPN)
T=0.00036 (6/16760, 8.3KJPN)
A=0.1522 (975/6404, 1000G_30x)
A=0.1478 (740/5008, 1000G)
A=0.2909 (1301/4472, Estonian)
A=0.2410 (929/3854, ALSPAC)
A=0.2562 (950/3708, TWINSUK)
A=0.0000 (0/2922, KOREAN)
A=0.1418 (295/2080, HGDP_Stanford)
A=0.1504 (234/1556, HapMap)
A=0.247 (247/998, GoNL)
A=0.004 (3/792, PRJEB37584)
A=0.255 (153/600, NorthernSweden)
A=0.152 (81/534, MGP)
A=0.224 (68/304, FINRISK)
A=0.153 (33/216, Qatari)
C=0.445 (49/110, SGDP_PRJ)
A=0.34 (22/64, Ancient Sardinia)
A=0.30 (12/40, GENOME_DK)
C=0.31 (5/16, Siberian)
Clinical Significance
Reported in ClinVar
Gene : Consequence
F13A1 : Missense Variant
LOC124901253 : Intron Variant
Publications
53 citations
Genomic View
See rs on genome

ALFA Allele Frequency
The ALFA project provide aggregate allele frequency from dbGaP. More information is available on the project page including descriptions, data access, and terms of use.

Release Version: 20231103111315
Population Group Sample Size Ref Allele Alt Allele Ref HMOZ Alt HMOZ HTRZ HWEP
Total Global 366122 C=0.769399 A=0.230601, T=0.000000 0.595894 0.057096 0.34701 32
European Sub 306476 C=0.756108 A=0.243892, T=0.000000 0.573742 0.061525 0.364733 11
African Sub 15566 C=0.84177 A=0.15823, T=0.00000 0.707953 0.024412 0.267635 0
African Others Sub 570 C=0.847 A=0.153, T=0.000 0.705263 0.010526 0.284211 2
African American Sub 14996 C=0.84156 A=0.15844, T=0.00000 0.708055 0.02494 0.267005 0
Asian Sub 6936 C=0.9986 A=0.0014, T=0.0000 0.997116 0.0 0.002884 0
East Asian Sub 4968 C=0.9986 A=0.0014, T=0.0000 0.997182 0.0 0.002818 0
Other Asian Sub 1968 C=0.9985 A=0.0015, T=0.0000 0.996951 0.0 0.003049 0
Latin American 1 Sub 1450 C=0.7917 A=0.2083, T=0.0000 0.633103 0.049655 0.317241 1
Latin American 2 Sub 6946 C=0.7587 A=0.2413, T=0.0000 0.579902 0.062482 0.357616 1
South Asian Sub 5210 C=0.8800 A=0.1200, T=0.0000 0.777735 0.017658 0.204607 2
Other Sub 23538 C=0.80436 A=0.19564, T=0.00000 0.654176 0.045458 0.300365 14


Help

Frequency tab displays a table of the reference and alternate allele frequencies reported by various studies and populations. Table lines, where Population="Global" refer to the entire study population, whereas lines, where Group="Sub", refer to a study-specific population subgroupings (i.e. AFR, CAU, etc.), if available. Frequency for the alternate allele (Alt Allele) is a ratio of samples observed-to-total, where the numerator (observed samples) is the number of chromosomes in the study with the minor allele present (found in "Sample size", where Group="Sub"), and the denominator (total samples) is the total number of all chromosomes in the study for the variant (found in "Sample size", where Group="Study-wide" and Population="Global").

Download
Study Population Group Sample Size Ref Allele Alt Allele
Allele Frequency Aggregator Total Global 349848 C=0.769468 A=0.230532, T=0.000000
Allele Frequency Aggregator European Sub 296470 C=0.756576 A=0.243424, T=0.000000
Allele Frequency Aggregator Other Sub 22100 C=0.80778 A=0.19222, T=0.00000
Allele Frequency Aggregator African Sub 10736 C=0.84892 A=0.15108, T=0.00000
Allele Frequency Aggregator Latin American 2 Sub 6946 C=0.7587 A=0.2413, T=0.0000
Allele Frequency Aggregator Asian Sub 6936 C=0.9986 A=0.0014, T=0.0000
Allele Frequency Aggregator South Asian Sub 5210 C=0.8800 A=0.1200, T=0.0000
Allele Frequency Aggregator Latin American 1 Sub 1450 C=0.7917 A=0.2083, T=0.0000
TopMed Global Study-wide 264690 C=0.783309 A=0.216691
gnomAD - Genomes Global Study-wide 139888 C=0.779981 A=0.220019
gnomAD - Genomes European Sub 75748 C=0.75050 A=0.24950
gnomAD - Genomes African Sub 41910 C=0.81453 A=0.18547
gnomAD - Genomes American Sub 13632 C=0.77296 A=0.22704
gnomAD - Genomes Ashkenazi Jewish Sub 3316 C=0.8311 A=0.1689
gnomAD - Genomes East Asian Sub 3130 C=0.9990 A=0.0010
gnomAD - Genomes Other Sub 2152 C=0.7918 A=0.2082
The PAGE Study Global Study-wide 78698 C=0.82170 A=0.17830
The PAGE Study AfricanAmerican Sub 32514 C=0.81057 A=0.18943
The PAGE Study Mexican Sub 10810 C=0.75069 A=0.24931
The PAGE Study Asian Sub 8316 C=0.9978 A=0.0022
The PAGE Study PuertoRican Sub 7918 C=0.7968 A=0.2032
The PAGE Study NativeHawaiian Sub 4534 C=0.9385 A=0.0615
The PAGE Study Cuban Sub 4230 C=0.7790 A=0.2210
The PAGE Study Dominican Sub 3828 C=0.8004 A=0.1996
The PAGE Study CentralAmerican Sub 2450 C=0.7098 A=0.2902
The PAGE Study SouthAmerican Sub 1982 C=0.7518 A=0.2482
The PAGE Study NativeAmerican Sub 1260 C=0.7738 A=0.2262
The PAGE Study SouthAsian Sub 856 C=0.901 A=0.099
14KJPN JAPANESE Study-wide 28258 C=0.99968 T=0.00032
8.3KJPN JAPANESE Study-wide 16760 C=0.99964 T=0.00036
1000Genomes_30x Global Study-wide 6404 C=0.8478 A=0.1522
1000Genomes_30x African Sub 1786 C=0.8354 A=0.1646
1000Genomes_30x Europe Sub 1266 C=0.7599 A=0.2401
1000Genomes_30x South Asian Sub 1202 C=0.9077 A=0.0923
1000Genomes_30x East Asian Sub 1170 C=0.9983 A=0.0017
1000Genomes_30x American Sub 980 C=0.731 A=0.269
1000Genomes Global Study-wide 5008 C=0.8522 A=0.1478
1000Genomes African Sub 1322 C=0.8359 A=0.1641
1000Genomes East Asian Sub 1008 C=0.9980 A=0.0020
1000Genomes Europe Sub 1006 C=0.7584 A=0.2416
1000Genomes South Asian Sub 978 C=0.907 A=0.093
1000Genomes American Sub 694 C=0.731 A=0.269
Genetic variation in the Estonian population Estonian Study-wide 4472 C=0.7091 A=0.2909
The Avon Longitudinal Study of Parents and Children PARENT AND CHILD COHORT Study-wide 3854 C=0.7590 A=0.2410
UK 10K study - Twins TWIN COHORT Study-wide 3708 C=0.7438 A=0.2562
KOREAN population from KRGDB KOREAN Study-wide 2922 C=1.0000 A=0.0000
HGDP-CEPH-db Supplement 1 Global Study-wide 2080 C=0.8582 A=0.1418
HGDP-CEPH-db Supplement 1 Est_Asia Sub 470 C=0.985 A=0.015
HGDP-CEPH-db Supplement 1 Central_South_Asia Sub 414 C=0.841 A=0.159
HGDP-CEPH-db Supplement 1 Middle_Est Sub 348 C=0.899 A=0.101
HGDP-CEPH-db Supplement 1 Europe Sub 318 C=0.736 A=0.264
HGDP-CEPH-db Supplement 1 Africa Sub 242 C=0.736 A=0.264
HGDP-CEPH-db Supplement 1 America Sub 216 C=0.819 A=0.181
HGDP-CEPH-db Supplement 1 Oceania Sub 72 C=1.00 A=0.00
HapMap Global Study-wide 1556 C=0.8496 A=0.1504
HapMap African Sub 692 C=0.867 A=0.133
HapMap American Sub 598 C=0.836 A=0.164
HapMap Europe Sub 176 C=0.750 A=0.250
HapMap Asian Sub 90 C=1.00 A=0.00
Genome of the Netherlands Release 5 Genome of the Netherlands Study-wide 998 C=0.753 A=0.247
CNV burdens in cranial meningiomas Global Study-wide 792 C=0.996 A=0.004
CNV burdens in cranial meningiomas CRM Sub 792 C=0.996 A=0.004
Northern Sweden ACPOP Study-wide 600 C=0.745 A=0.255
Medical Genome Project healthy controls from Spanish population Spanish controls Study-wide 534 C=0.848 A=0.152
FINRISK Finnish from FINRISK project Study-wide 304 C=0.776 A=0.224
Qatari Global Study-wide 216 C=0.847 A=0.153
SGDP_PRJ Global Study-wide 110 C=0.445 A=0.555
Ancient Sardinia genome-wide 1240k capture data generation and analysis Global Study-wide 64 C=0.66 A=0.34
The Danish reference pan genome Danish Study-wide 40 C=0.70 A=0.30
Siberian Global Study-wide 16 C=0.31 A=0.69
Help

Variant Details tab shows known variant placements on genomic sequences: chromosomes (NC_), RefSeqGene, pseudogenes or genomic regions (NG_), and in a separate table: on transcripts (NM_) and protein sequences (NP_). The corresponding transcript and protein locations are listed in adjacent lines, along with molecular consequences from Sequence Ontology. When no protein placement is available, only the transcript is listed. Column "Codon[Amino acid]" shows the actual base change in the format of "Reference > Alternate" allele, including the nucleotide codon change in transcripts, and the amino acid change in proteins, respectively, allowing for known ribosomal slippage sites. To view nucleotides adjacent to the variant use the Genomic View at the bottom of the page - zoom into the sequence until the nucleotides around the variant become visible.

Genomic Placements
Sequence name Change
GRCh38.p14 chr 6 NC_000006.12:g.6318562C>A
GRCh38.p14 chr 6 NC_000006.12:g.6318562C>T
GRCh37.p13 chr 6 NC_000006.11:g.6318795C>A
GRCh37.p13 chr 6 NC_000006.11:g.6318795C>T
F13A1 RefSeqGene (LRG_549) NG_008107.1:g.7130G>T
F13A1 RefSeqGene (LRG_549) NG_008107.1:g.7130G>A
Gene: F13A1, coagulation factor XIII A chain (minus strand)
Molecule type Change Amino acid[Codon] SO Term
F13A1 transcript NM_000129.4:c.103G>T V [GTG] > L [TTG] Coding Sequence Variant
coagulation factor XIII A chain NP_000120.2:p.Val35Leu V (Val) > L (Leu) Missense Variant
F13A1 transcript NM_000129.4:c.103G>A V [GTG] > M [ATG] Coding Sequence Variant
coagulation factor XIII A chain NP_000120.2:p.Val35Met V (Val) > M (Met) Missense Variant
Gene: LOC124901253, uncharacterized LOC124901253 (plus strand)
Molecule type Change Amino acid[Codon] SO Term
LOC124901253 transcript XR_007059428.1:n. N/A Intron Variant
Help

Clinical Significance tab shows a list of clinical significance entries from ClinVar associated with the variation, per allele. Click on the RCV accession (i.e. RCV000001615.2) or Allele ID (i.e. 12274) to access full ClinVar report.

Allele: A (allele ID: 31571 )
ClinVar Accession Disease Names Clinical Significance
RCV000017996.3 Myocardial infarction, protection against Protective
RCV000017997.3 Venous thrombosis, protection against Protective
RCV000248039.1 not specified Benign
RCV000374698.3 Factor XIII, A subunit, deficiency of Benign
RCV000998517.10 not provided Conflicting-Interpretations-Of-Pathogenicity
Help

Aliases tab displays HGVS names representing the variant placements and allele changes on genomic, transcript and protein sequences, per allele. HGVS name is an expression for reporting sequence accession and version, sequence type, position, and allele change. The column "Note" can have two values: "diff" means that there is a difference between the reference allele (variation interval) at the placement reported in HGVS name and the reference alleles reported in other HGVS names, and "rev" means that the sequence of this variation interval at the placement reported in HGVS name is in reverse orientation to the sequence(s) of this variation in other HGVS names not labeled as "rev".

Placement C= A T
GRCh38.p14 chr 6 NC_000006.12:g.6318562= NC_000006.12:g.6318562C>A NC_000006.12:g.6318562C>T
GRCh37.p13 chr 6 NC_000006.11:g.6318795= NC_000006.11:g.6318795C>A NC_000006.11:g.6318795C>T
F13A1 RefSeqGene (LRG_549) NG_008107.1:g.7130= NG_008107.1:g.7130G>T NG_008107.1:g.7130G>A
F13A1 transcript NM_000129.4:c.103= NM_000129.4:c.103G>T NM_000129.4:c.103G>A
F13A1 transcript NM_000129.3:c.103= NM_000129.3:c.103G>T NM_000129.3:c.103G>A
coagulation factor XIII A chain NP_000120.2:p.Val35= NP_000120.2:p.Val35Leu NP_000120.2:p.Val35Met
Help

Submissions tab displays variations originally submitted to dbSNP, now supporting this RefSNP cluster (rs). We display Submitter handle, Submission identifier, Date and Build number, when the submission appeared for the first time. Direct submissions to dbSNP have Submission ID in the form of an ss-prefixed number (ss#). Other supporting variations are listed in the table without ss#.

162 SubSNP, 28 Frequency, 5 ClinVar submissions
No Submitter Submission ID Date (Build)
1 WIAF-CSNP ss7595 Sep 19, 2000 (52)
2 PGA-UW-FHCRC ss4250177 Jan 04, 2002 (102)
3 BCM_SSAHASNP ss10296105 Jul 11, 2003 (116)
4 CSHL-HAPMAP ss19693415 Feb 27, 2004 (120)
5 ABI ss42773612 Mar 15, 2006 (126)
6 PGA-UW-FHCRC ss52086596 Oct 16, 2006 (127)
7 ILLUMINA ss65728741 Oct 16, 2006 (127)
8 ILLUMINA ss66719414 Dec 01, 2006 (127)
9 ILLUMINA ss67431772 Dec 01, 2006 (127)
10 ILLUMINA ss67788087 Dec 01, 2006 (127)
11 ILLUMINA ss70852820 May 26, 2008 (130)
12 ILLUMINA ss71438500 May 18, 2007 (127)
13 ILLUMINA ss75830178 Dec 07, 2007 (129)
14 SI_EXO ss76896196 Dec 07, 2007 (129)
15 ILLUMINA ss79213420 Dec 15, 2007 (130)
16 KRIBB_YJKIM ss83347007 Dec 15, 2007 (130)
17 1000GENOMES ss109722565 Jan 24, 2009 (130)
18 1000GENOMES ss113847069 Jan 25, 2009 (130)
19 ILLUMINA ss122496149 Dec 01, 2009 (131)
20 ILLUMINA ss154347385 Dec 01, 2009 (131)
21 ILLUMINA ss159523695 Dec 01, 2009 (131)
22 SEATTLESEQ ss159711180 Dec 01, 2009 (131)
23 ILLUMINA ss160754923 Dec 01, 2009 (131)
24 COMPLETE_GENOMICS ss161991249 Jul 04, 2010 (132)
25 COMPLETE_GENOMICS ss163100051 Jul 04, 2010 (132)
26 COMPLETE_GENOMICS ss166083355 Jul 04, 2010 (132)
27 ILLUMINA ss172075427 Jul 04, 2010 (132)
28 ILLUMINA ss173956338 Jul 04, 2010 (132)
29 BUSHMAN ss201372842 Jul 04, 2010 (132)
30 1000GENOMES ss222187971 Jul 14, 2010 (132)
31 1000GENOMES ss233308161 Jul 14, 2010 (132)
32 ILLUMINA ss244303976 Jul 04, 2010 (132)
33 OMIM-CURATED-RECORDS ss275514529 Nov 22, 2010 (133)
34 PJP ss293669734 May 09, 2011 (134)
35 NHLBI-ESP ss342200616 May 09, 2011 (134)
36 ILLUMINA ss481184502 May 04, 2012 (137)
37 ILLUMINA ss481207448 May 04, 2012 (137)
38 ILLUMINA ss482194491 Sep 08, 2015 (146)
39 ILLUMINA ss485387463 May 04, 2012 (137)
40 1000GENOMES ss490918976 May 04, 2012 (137)
41 EXOME_CHIP ss491377327 May 04, 2012 (137)
42 CLINSEQ_SNP ss491880278 May 04, 2012 (137)
43 ILLUMINA ss537327398 Sep 08, 2015 (146)
44 TISHKOFF ss558979374 Apr 25, 2013 (138)
45 SSMP ss652889059 Apr 25, 2013 (138)
46 ILLUMINA ss778561903 Sep 08, 2015 (146)
47 ILLUMINA ss780845239 Sep 08, 2015 (146)
48 ILLUMINA ss783139276 Sep 08, 2015 (146)
49 ILLUMINA ss783528764 Sep 08, 2015 (146)
50 ILLUMINA ss784095579 Sep 08, 2015 (146)
51 ILLUMINA ss825543938 Apr 01, 2015 (144)
52 ILLUMINA ss832398346 Sep 08, 2015 (146)
53 ILLUMINA ss833034964 Jul 13, 2019 (153)
54 ILLUMINA ss834018820 Sep 08, 2015 (146)
55 EVA-GONL ss982544623 Aug 21, 2014 (142)
56 JMKIDD_LAB ss1067475070 Aug 21, 2014 (142)
57 JMKIDD_LAB ss1073351792 Aug 21, 2014 (142)
58 1000GENOMES ss1318822643 Aug 21, 2014 (142)
59 EVA_GENOME_DK ss1581516165 Apr 01, 2015 (144)
60 EVA_FINRISK ss1584043563 Apr 01, 2015 (144)
61 EVA_DECODE ss1592091482 Apr 01, 2015 (144)
62 EVA_UK10K_ALSPAC ss1614869283 Apr 01, 2015 (144)
63 EVA_UK10K_TWINSUK ss1657863316 Apr 01, 2015 (144)
64 EVA_EXAC ss1688147320 Apr 01, 2015 (144)
65 EVA_EXAC ss1688147321 Apr 01, 2015 (144)
66 EVA_MGP ss1711111163 Apr 01, 2015 (144)
67 EVA_SVP ss1712832593 Apr 01, 2015 (144)
68 ILLUMINA ss1752643861 Sep 08, 2015 (146)
69 ILLUMINA ss1752643862 Sep 08, 2015 (146)
70 HAMMER_LAB ss1804263328 Sep 08, 2015 (146)
71 ILLUMINA ss1917798947 Feb 12, 2016 (147)
72 WEILL_CORNELL_DGM ss1925803273 Feb 12, 2016 (147)
73 ILLUMINA ss1946166471 Feb 12, 2016 (147)
74 ILLUMINA ss1958859444 Feb 12, 2016 (147)
75 JJLAB ss2023516736 Sep 14, 2016 (149)
76 ILLUMINA ss2094820200 Dec 20, 2016 (150)
77 ILLUMINA ss2095169642 Dec 20, 2016 (150)
78 USC_VALOUEV ss2151678963 Dec 20, 2016 (150)
79 HUMAN_LONGEVITY ss2281473498 Dec 20, 2016 (150)
80 ILLUMINA ss2634394685 Nov 08, 2017 (151)
81 GRF ss2707264604 Nov 08, 2017 (151)
82 GNOMAD ss2735521938 Nov 08, 2017 (151)
83 GNOMAD ss2747541699 Nov 08, 2017 (151)
84 GNOMAD ss2835374831 Nov 08, 2017 (151)
85 AFFY ss2985352375 Nov 08, 2017 (151)
86 AFFY ss2985980424 Nov 08, 2017 (151)
87 SWEGEN ss2998454877 Nov 08, 2017 (151)
88 ILLUMINA ss3022571004 Nov 08, 2017 (151)
89 BIOINF_KMB_FNS_UNIBA ss3025542539 Nov 08, 2017 (151)
90 CSHL ss3346818543 Nov 08, 2017 (151)
91 ILLUMINA ss3629435083 Oct 12, 2018 (152)
92 ILLUMINA ss3629435084 Oct 12, 2018 (152)
93 ILLUMINA ss3632315205 Oct 12, 2018 (152)
94 ILLUMINA ss3633404693 Oct 12, 2018 (152)
95 ILLUMINA ss3634126638 Oct 12, 2018 (152)
96 ILLUMINA ss3635042497 Oct 12, 2018 (152)
97 ILLUMINA ss3635042498 Oct 12, 2018 (152)
98 ILLUMINA ss3635808002 Oct 12, 2018 (152)
99 ILLUMINA ss3636757136 Oct 12, 2018 (152)
100 ILLUMINA ss3637560715 Oct 12, 2018 (152)
101 ILLUMINA ss3638604827 Oct 12, 2018 (152)
102 ILLUMINA ss3639305083 Oct 12, 2018 (152)
103 ILLUMINA ss3639677435 Oct 12, 2018 (152)
104 ILLUMINA ss3640749792 Oct 12, 2018 (152)
105 ILLUMINA ss3640749793 Oct 12, 2018 (152)
106 ILLUMINA ss3643546795 Oct 12, 2018 (152)
107 ILLUMINA ss3644899532 Oct 12, 2018 (152)
108 OMUKHERJEE_ADBS ss3646330363 Oct 12, 2018 (152)
109 ILLUMINA ss3653078886 Oct 12, 2018 (152)
110 ILLUMINA ss3653078887 Oct 12, 2018 (152)
111 ILLUMINA ss3654120654 Oct 12, 2018 (152)
112 EGCUT_WGS ss3666378357 Jul 13, 2019 (153)
113 EVA_DECODE ss3716507940 Jul 13, 2019 (153)
114 ILLUMINA ss3726307029 Jul 13, 2019 (153)
115 ACPOP ss3733169349 Jul 13, 2019 (153)
116 ILLUMINA ss3744545369 Jul 13, 2019 (153)
117 ILLUMINA ss3745342607 Jul 13, 2019 (153)
118 ILLUMINA ss3745342608 Jul 13, 2019 (153)
119 EVA ss3764566173 Jul 13, 2019 (153)
120 PAGE_CC ss3771259770 Jul 13, 2019 (153)
121 ILLUMINA ss3772836429 Jul 13, 2019 (153)
122 ILLUMINA ss3772836430 Jul 13, 2019 (153)
123 PACBIO ss3785361449 Jul 13, 2019 (153)
124 PACBIO ss3790728662 Jul 13, 2019 (153)
125 PACBIO ss3795605846 Jul 13, 2019 (153)
126 KHV_HUMAN_GENOMES ss3807727509 Jul 13, 2019 (153)
127 EVA ss3824153079 Apr 26, 2020 (154)
128 EVA ss3829711736 Apr 26, 2020 (154)
129 EVA ss3838330679 Apr 26, 2020 (154)
130 EVA ss3843770673 Apr 26, 2020 (154)
131 HGDP ss3847821450 Apr 26, 2020 (154)
132 SGDP_PRJ ss3863840824 Apr 26, 2020 (154)
133 KRGDB ss3910577023 Apr 26, 2020 (154)
134 FSA-LAB ss3984328201 Apr 26, 2021 (155)
135 FSA-LAB ss3984328202 Apr 26, 2021 (155)
136 EVA ss3984560843 Apr 26, 2021 (155)
137 EVA ss3985197030 Apr 26, 2021 (155)
138 EVA ss3986334985 Apr 26, 2021 (155)
139 TOPMED ss4692417694 Apr 26, 2021 (155)
140 TOMMO_GENOMICS ss5175990853 Apr 26, 2021 (155)
141 EVA ss5237019536 Apr 26, 2021 (155)
142 EVA ss5237645085 Oct 13, 2022 (156)
143 1000G_HIGH_COVERAGE ss5267268545 Oct 13, 2022 (156)
144 TRAN_CS_UWATERLOO ss5314414972 Oct 13, 2022 (156)
145 EVA ss5315118878 Oct 13, 2022 (156)
146 EVA ss5363569818 Oct 13, 2022 (156)
147 HUGCELL_USP ss5465072594 Oct 13, 2022 (156)
148 1000G_HIGH_COVERAGE ss5552631789 Oct 13, 2022 (156)
149 EVA ss5624154227 Oct 13, 2022 (156)
150 SANFORD_IMAGENETICS ss5624613627 Oct 13, 2022 (156)
151 SANFORD_IMAGENETICS ss5639692624 Oct 13, 2022 (156)
152 TOMMO_GENOMICS ss5713609596 Oct 13, 2022 (156)
153 EVA ss5799674862 Oct 13, 2022 (156)
154 EVA ss5800054999 Oct 13, 2022 (156)
155 EVA ss5841740960 Oct 13, 2022 (156)
156 EVA ss5846863331 Oct 13, 2022 (156)
157 EVA ss5847283155 Oct 13, 2022 (156)
158 EVA ss5848079476 Oct 13, 2022 (156)
159 EVA ss5848644829 Oct 13, 2022 (156)
160 EVA ss5882502490 Oct 13, 2022 (156)
161 EVA ss5968187449 Oct 13, 2022 (156)
162 EVA ss5979768792 Oct 13, 2022 (156)
163 1000Genomes NC_000006.11 - 6318795 Oct 12, 2018 (152)
164 1000Genomes_30x NC_000006.12 - 6318562 Oct 13, 2022 (156)
165 The Avon Longitudinal Study of Parents and Children NC_000006.11 - 6318795 Oct 12, 2018 (152)
166 Genetic variation in the Estonian population NC_000006.11 - 6318795 Oct 12, 2018 (152)
167 ExAC

Submission ignored due to conflicting rows:
Row 8165104 (NC_000006.11:6318794:C:C 96378/121372, NC_000006.11:6318794:C:A 24994/121372)
Row 8165105 (NC_000006.11:6318794:C:C 121368/121372, NC_000006.11:6318794:C:T 4/121372)

- Oct 12, 2018 (152)
168 ExAC

Submission ignored due to conflicting rows:
Row 8165104 (NC_000006.11:6318794:C:C 96378/121372, NC_000006.11:6318794:C:A 24994/121372)
Row 8165105 (NC_000006.11:6318794:C:C 121368/121372, NC_000006.11:6318794:C:T 4/121372)

- Oct 12, 2018 (152)
169 FINRISK NC_000006.11 - 6318795 Apr 26, 2020 (154)
170 The Danish reference pan genome NC_000006.11 - 6318795 Apr 26, 2020 (154)
171 gnomAD - Genomes NC_000006.12 - 6318562 Apr 26, 2021 (155)
172 gnomAD - Exomes

Submission ignored due to conflicting rows:
Row 4657502 (NC_000006.11:6318794:C:C 199540/250876, NC_000006.11:6318794:C:A 51336/250876)
Row 4657503 (NC_000006.11:6318794:C:C 250870/250876, NC_000006.11:6318794:C:T 6/250876)

- Jul 13, 2019 (153)
173 gnomAD - Exomes

Submission ignored due to conflicting rows:
Row 4657502 (NC_000006.11:6318794:C:C 199540/250876, NC_000006.11:6318794:C:A 51336/250876)
Row 4657503 (NC_000006.11:6318794:C:C 250870/250876, NC_000006.11:6318794:C:T 6/250876)

- Jul 13, 2019 (153)
174 Genome of the Netherlands Release 5 NC_000006.11 - 6318795 Apr 26, 2020 (154)
175 HGDP-CEPH-db Supplement 1 NC_000006.10 - 6263794 Apr 26, 2020 (154)
176 HapMap NC_000006.12 - 6318562 Apr 26, 2020 (154)
177 KOREAN population from KRGDB NC_000006.11 - 6318795 Apr 26, 2020 (154)
178 Medical Genome Project healthy controls from Spanish population NC_000006.11 - 6318795 Apr 26, 2020 (154)
179 Northern Sweden NC_000006.11 - 6318795 Jul 13, 2019 (153)
180 The PAGE Study NC_000006.12 - 6318562 Jul 13, 2019 (153)
181 Ancient Sardinia genome-wide 1240k capture data generation and analysis NC_000006.11 - 6318795 Apr 26, 2021 (155)
182 CNV burdens in cranial meningiomas NC_000006.11 - 6318795 Apr 26, 2021 (155)
183 Qatari NC_000006.11 - 6318795 Apr 26, 2020 (154)
184 SGDP_PRJ NC_000006.11 - 6318795 Apr 26, 2020 (154)
185 Siberian NC_000006.11 - 6318795 Apr 26, 2020 (154)
186 8.3KJPN NC_000006.11 - 6318795 Apr 26, 2021 (155)
187 14KJPN NC_000006.12 - 6318562 Oct 13, 2022 (156)
188 TopMed NC_000006.12 - 6318562 Apr 26, 2021 (155)
189 UK 10K study - Twins NC_000006.11 - 6318795 Oct 12, 2018 (152)
190 ALFA NC_000006.12 - 6318562 Apr 26, 2021 (155)
191 ClinVar RCV000017996.3 Oct 12, 2018 (152)
192 ClinVar RCV000017997.3 Oct 12, 2018 (152)
193 ClinVar RCV000248039.1 Oct 12, 2018 (152)
194 ClinVar RCV000374698.3 Oct 13, 2022 (156)
195 ClinVar RCV000998517.10 Oct 13, 2022 (156)
Help

History tab displays RefSNPs (Associated ID) from previous builds (Build) that now support the current RefSNP, and the dates, when the history was updated for each Associated ID (History Updated).

Associated ID History Updated (Build)
rs60452761 May 26, 2008 (130)
Added to this RefSNP Cluster:
Submission IDs Observation SPDI Canonical SPDI Source RSIDs
ss3639305083, ss3639677435 NC_000006.9:6263793:C:A NC_000006.12:6318561:C:A (self)
499342, ss109722565, ss113847069, ss161991249, ss163100051, ss166083355, ss201372842, ss293669734, ss481184502, ss491880278, ss825543938, ss1592091482, ss1712832593, ss3643546795, ss3847821450 NC_000006.10:6263793:C:A NC_000006.12:6318561:C:A (self)
30559391, 17012518, 12116605, 40024, 7681104, 7550669, 17754417, 226923, 6454214, 422957, 110218, 7845203, 15857804, 4195317, 17012518, ss222187971, ss233308161, ss342200616, ss481207448, ss482194491, ss485387463, ss490918976, ss491377327, ss537327398, ss558979374, ss652889059, ss778561903, ss780845239, ss783139276, ss783528764, ss784095579, ss832398346, ss833034964, ss834018820, ss982544623, ss1067475070, ss1073351792, ss1318822643, ss1581516165, ss1584043563, ss1614869283, ss1657863316, ss1688147320, ss1711111163, ss1752643861, ss1752643862, ss1804263328, ss1917798947, ss1925803273, ss1946166471, ss1958859444, ss2023516736, ss2094820200, ss2095169642, ss2151678963, ss2634394685, ss2707264604, ss2735521938, ss2747541699, ss2835374831, ss2985352375, ss2985980424, ss2998454877, ss3022571004, ss3346818543, ss3629435083, ss3629435084, ss3632315205, ss3633404693, ss3634126638, ss3635042497, ss3635042498, ss3635808002, ss3636757136, ss3637560715, ss3638604827, ss3640749792, ss3640749793, ss3644899532, ss3646330363, ss3653078886, ss3653078887, ss3654120654, ss3666378357, ss3733169349, ss3744545369, ss3745342607, ss3745342608, ss3764566173, ss3772836429, ss3772836430, ss3785361449, ss3790728662, ss3795605846, ss3824153079, ss3829711736, ss3838330679, ss3863840824, ss3910577023, ss3984328201, ss3984328202, ss3984560843, ss3985197030, ss3986334985, ss5315118878, ss5363569818, ss5624154227, ss5624613627, ss5639692624, ss5799674862, ss5800054999, ss5841740960, ss5846863331, ss5847283155, ss5848079476, ss5848644829, ss5968187449, ss5979768792 NC_000006.11:6318794:C:A NC_000006.12:6318561:C:A (self)
RCV000017996.3, RCV000017997.3, RCV000248039.1, RCV000374698.3, RCV000998517.10, 40157724, 216037414, 3052437, 481239, 529795252, 10624573448, ss275514529, ss2281473498, ss3025542539, ss3716507940, ss3726307029, ss3771259770, ss3807727509, ss3843770673, ss4692417694, ss5237019536, ss5237645085, ss5267268545, ss5314414972, ss5465072594, ss5552631789, ss5882502490 NC_000006.12:6318561:C:A NC_000006.12:6318561:C:A (self)
ss7595, ss4250177, ss42773612, ss52086596, ss65728741, ss66719414, ss67431772, ss67788087, ss70852820, ss71438500, ss75830178, ss79213420, ss83347007, ss122496149, ss154347385, ss159523695, ss159711180, ss160754923, ss172075427, ss173956338, ss244303976 NT_007592.15:6258794:C:A NC_000006.12:6318561:C:A (self)
ss10296105 NT_034880.2:6258793:C:A NC_000006.12:6318561:C:A (self)
ss19693415, ss76896196 NT_034880.3:6258793:C:A NC_000006.12:6318561:C:A (self)
33960160, ss1688147321, ss2735521938, ss5175990853 NC_000006.11:6318794:C:T NC_000006.12:6318561:C:T (self)
47446700, 10624573448, ss5713609596 NC_000006.12:6318561:C:T NC_000006.12:6318561:C:T (self)
Help

Publications tab displays PubMed articles citing the variation as a listing of PMID, Title, Author, Year, Journal, ordered by Year, descending.

53 citations for rs5985
PMID Title Author Year Journal
8025280 Deficiency in the A-subunit of coagulation factor XIII: two novel point mutations demonstrate different effects on transcript levels. Mikkola H et al. 1994 Blood
9459313 Association of a common polymorphism in the factor XIII gene with myocardial infarction. Kohler HP et al. 1998 Thrombosis and haemostasis
9550516 Factor XIII Val 34 Leu: a novel association with primary intracerebral hemorrhage. Catto AJ et al. 1998 Stroke
10365735 Factor XIII Val34Leu is a genetic factor involved in the etiology of venous thrombosis. Franco RF et al. 1999 Thrombosis and haemostasis
10910914 The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure. Ariëns RA et al. 2000 Blood
12072871 The effect of the Val34Leu polymorphism in the factor XIII gene in infants with a birth weight below 1500 g. Göpel W et al. 2002 The Journal of pediatrics
12456499 Genetic variants of coagulation factor XIII, postmenopausal estrogen therapy, and risk of nonfatal myocardial infarction. Reiner AP et al. 2003 Blood
16525568 Epistatic and pleiotropic effects of polymorphisms in the fibrinogen and coagulation factor XIII genes on plasma fibrinogen concentration, fibrin gel structure and risk of myocardial infarction. Mannila MN et al. 2006 Thrombosis and haemostasis
16681647 Sickle cell leg ulcers: associations with haemolysis and SNPs in Klotho, TEK and genes of the TGF-beta/BMP pathway. Nolan VG et al. 2006 British journal of haematology
16740590 Factor XIII Val34Leu variant is protective against venous thromboembolism: a HuGE review and meta-analysis. Wells PS et al. 2006 American journal of epidemiology
17107626 Comparison of PrASE and Pyrosequencing for SNP Genotyping. Käller M et al. 2006 BMC genomics
17241179 The association between fibrinogen haplotypes and myocardial infarction in men is partly mediated through pleiotropic effects on the serum IL-6 concentration. Mannila MN et al. 2007 Journal of internal medicine
17393027 Factor XIII Val34Leu variant and the risk of myocardial infarction: a meta-analysis. Shafey M et al. 2007 Thrombosis and haemostasis
17975119 Association of gene variants with incident myocardial infarction in the Cardiovascular Health Study. Shiffman D et al. 2008 Arteriosclerosis, thrombosis, and vascular biology
20031584 Genetics of atherothrombotic and lacunar stroke. Debette S et al. 2009 Circulation. Cardiovascular genetics
20227257 Polymorphisms in the platelet-specific collagen receptor GP6 are associated with risk of nonfatal myocardial infarction in Caucasians. Shaffer JR et al. 2011 Nutrition, metabolism, and cardiovascular diseases
20417488 Association of fetal inflammation and coagulation pathway gene polymorphisms with neurodevelopmental delay at age 2 years. Clark EA et al. 2010 American journal of obstetrics and gynecology
20532202 Use of genome-wide expression data to mine the "Gray Zone" of GWA studies leads to novel candidate obesity genes. Naukkarinen J et al. 2010 PLoS genetics
20887247 Pharmacogenetic aspects in therapeutic management of subfoveal choroidal neovascularisation: role of factor XIII-A 185 T-allele. Parmeggiani F et al. 2011 Current drug targets
21149552 Heterogeneity of the phenotypic definition of coronary artery disease and its impact on genetic association studies. Kitsios GD et al. 2011 Circulation. Cardiovascular genetics
21332313 Sequence variations in the FII, FV, F13A1, FGB and PAI-1 genes are associated with differences in myocardial perfusion. Satra M et al. 2011 Pharmacogenomics
21422408 Clotting factor gene polymorphisms and colorectal cancer risk. Vossen CY et al. 2011 Journal of clinical oncology
21659962 Replication of genetic associations in the inflammation, complement, and coagulation pathways with intraventricular hemorrhage in LBW preterm neonates. Ryckman KK et al. 2011 Pediatric research
21992066 Challenges in the association of human single nucleotide polymorphism mentions with unique database identifiers. Thomas PE et al. 2011 BMC bioinformatics
22267327 Fibrinogen and factor XIII A-subunit genotypes interactively influence C-reactive protein levels during inflammation. Hoppe B et al. 2012 Annals of the rheumatic diseases
22794791 Exploring the interaction between SNP genotype and postmenopausal hormone therapy effects on stroke risk. Huang Y et al. 2012 Genome medicine
22905135 Association between variant Y402H in age-related macular degeneration (AMD) susceptibility gene CFH and treatment response of AMD: a meta-analysis. Chen H et al. 2012 PloS one
22909824 Activity and levels of factor XIII in a Venezuelan admixed population: association with rs5985 (Val35Leu) and STR F13A01 polymorphisms. Vívenes M et al. 2012 Thrombosis research
23209669 Effect of the Gas6 c.834+7G>A polymorphism and the interaction of known risk factors on AMD pathogenesis in Hungarian patients. Losonczy G et al. 2012 PloS one
23820649 Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease. Cooper DN et al. 2013 Human genetics
25156046 Genetic polymorphisms influencing total and γ' fibrinogen levels and fibrin clot properties in Africans. Kotzé RC et al. 2015 British journal of haematology
25341889 Multilocus genetic risk scores for venous thromboembolism risk assessment. Soria JM et al. 2014 Journal of the American Heart Association
25360888 Genetic determinants of on-aspirin platelet reactivity: focus on the influence of PEAR1. Würtz M et al. 2014 PloS one
25741868 Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Richards S et al. 2015 Genetics in medicine
25862345 Genetic association between FXIII and β-fibrinogen genes and women with recurrent spontaneous abortion: a meta- analysis. Li J et al. 2015 Journal of assisted reproduction and genetics
26307969 Effect of Factor XIII-A G185T Polymorphism on Visual Prognosis after Photodynamic Therapy for Neovascular Macular Degeneration. Parmeggiani F et al. 2015 International journal of molecular sciences
26791477 The effects of genes implicated in cardiovascular disease on blood pressure response to treatment among treatment-naive hypertensive African Americans in the GenHAT study. Do AN et al. 2016 Journal of human hypertension
27253732 Pharmacogenomic incidental findings in 308 families: The NIH Undiagnosed Diseases Program experience. Lee EM et al. 2016 Genetics in medicine
27589735 A Genomics-Based Model for Prediction of Severe Bioprosthetic Mitral Valve Calcification. Ponasenko AV et al. 2016 International journal of molecular sciences
27766050 Causes of venous thrombosis. Rosendaal FR et al. 2016 Thrombosis journal
27976734 The Unravelling of the Genetic Architecture of Plasminogen Deficiency and its Relation to Thrombotic Disease. Martin-Fernandez L et al. 2016 Scientific reports
28978253 Coagulation F13A1 V34L, fibrinogen and homocysteine versus conventional risk factors in the pathogenesis of MI in young persons. Vishwajeet V et al. 2018 Acta cardiologica
30185149 Factor XIII polymorphism and risk of aneurysmal subarachnoid haemorrhage in a south Indian population. Suvatha A et al. 2018 BMC medical genetics
30446716 Inherited genetic predispositions in F13A1 and F13B genes predict abdominal adhesion formation: identification of gender prognostic indicators. Gemmati D et al. 2018 Scientific reports
31058051 Recurrent Miscarriage and Implantation Failure of Unknown Cause Studied by a Panel of Thrombophilia Conditions: Increased Frequency of FXIII Val34Leu Polymorphism. Diaz-Nuñez M et al. 2019 Journal of reproduction & infertility
31615384 [Hemostatic Gene Polymorphisms in Acute Coronary Syndrome with Nonobstructive Coronary Atherosclerosis]. Fedorova SB et al. 2019 Kardiologiia
32408093 Fibrinogen, factor XIII and α(2)-antiplasmin genotypes are associated with inflammatory activity and anti-citrullinated protein antibodies. Hoppe B et al. 2020 Thrombosis research
32548915 Coagulation factor XIII activity predicts left ventricular remodelling after acute myocardial infarction. Frey A et al. 2020 ESC heart failure
33128086 Genetic association study of fatal pulmonary embolism. Meißner L et al. 2021 International journal of legal medicine
34207366 Cis-Segregation of c.1171C>T Stop Codon (p.R391*) in SERPINC1 Gene and c.1691G>A Transition (p.R506Q) in F5 Gene and Selected GWAS Multilocus Approach in Inherited Thrombophilia. Gemmati D et al. 2021 Genes
34263111 Predictive Ability of a Clinical-Genetic Risk Score for Venous Thromboembolism in Northern and Southern European Populations. Salas E et al. 2021 TH open
34783023 Fibrinogen β chain and FXIII polymorphisms affect fibrin clot properties in acute pulmonary embolism. Klajmon A et al. 2022 European journal of clinical investigation
35671883 Factor XIII-A Val34Leu and Tyr204Phe variants influence clot kinetics in a cohort of South African type 2 diabetes mellitus patients. Phasha MN et al. 2022 Gene
Help

The Flanks tab provides retrieving flanking sequences of a SNP on all molecules that have placements.

Genome context:
Select flank length:

Genomic regions, transcripts, and products
Top Help

NCBI Graphical Sequence Viewer display of the genomic region, transcripts and protein products for the reported RefSNP (rs).
Use the zoom option to view the nucleotides around the RefSNP and find other neighboring RefSNPs.
Visit Sequence Viewer for help with navigating inside the display and modifying the selection of displayed data tracks.

Software version is: 2.0.1.post820+afb47a3d